Skip to main content

Estudio de fase III, multicéntrico, aleatorizado, doble ciego, controlado con placebo y de grupos paralelos para evaLuar la efIcacia y la seguridad de abeLacimab en pacientes de alto riesgo con fibrilación Auricular que no se consideren adecuados para la antiCoagulación oral

  • Protocol code: ANT-010
  • EudraCT code: No aplica
  • Pathology: Tumors
  • Principal investigator:  Olivera Sumire, Pável Eduardo
  • Service: Hematologia i Hematoteràpia
  • Phase: Fase III
  • Recruiting: Closed
  • Status: Iniciat

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

A randomized, double-blind, placebo-controlled, parallelgroup,Proof-of-Concept (PoC) study to assess theefficacy,safety and tolerability of itepekimab in participants with non-cystic fibrosis bronchiectasis

  • Protocol code: ACT18018
  • EudraCT code: No aplica
  • Pathology: Malalties del sistema respiratori
  • Principal investigator:  Polverino , Eva
  • Research group:  Pneumologia
  • Service: Pneumologia
  • Phase: Fase I
  • Recruiting: Open
  • Status: Iniciat

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.
Ubicació
Sala d’actes de la planta baixa de l'Hospital de Traumatologia, Rehabilitació i Cremats
Etiqueta
Jornades

30 years of research

Video library: 30 years of media appearances

Ubicació
Sala d’actes de la planta 1 del Pavelló Docent
Etiqueta
Jornades
Ubicació
Sala d’actes de la planta 1 del Pavelló Docent
Etiqueta
Jornades

Història del VHIR

Ubicació
Sala d’actes de la planta baixa de l’Hospital General
Etiqueta
Vall d'Hebron Talks by VHIR
Subscribe to